cov pid 1 [ . . . . : . . . 80 1 CYT2_MOUSE/1-9 100.0% 100.0% EIIGGL--SEAR----PATSEIQEIADKVRPLLEEKT--NEKYE---KFKAIE-YKVQVVQGLNYFIKMNVGRGCYL--- 2 CYT3_MOUSE/1-9 100.0% 58.8% MSLGGV--SEAS----RATPEIQMIANKVRPQLEAKT--NKKYE---KFEAVE-YKTQVVAGENIFIKMDVGHGCFI--- 3 CYTA_RAT/1-97 96.9% 57.0% GIVGGV--SEAK----PATPEIQEVADKVKRQLEEKT--NEKYE---KFKVVE-YKSQVVAGQILFMKVDVGNGRF---- 4 CYTA_BOVIN/1-9 97.9% 54.0% MIPGGL--TEAK----PATIEIQEIANMVKPQLEEKT--NETYE---EFTAIE-YKSQVVAGINYYIKIQTGDNR----- 5 CYTB_BOVIN/1-9 94.8% 45.6% MMCGGT--SATQ----PATAETQAIADKVKSQLEEKE--NKKFP---VFKALE-FKSQLVAGKNYFIKVQVD-------- 6 CYTD_HUMAN/1-1 93.8% 9.3% TLAGGI--HATD----LNDKSVQCALDFAISEYNKVIN-KDEYYSR-PLQVMA-AYQQIVGGVNYYFNVKFG-------- 7 CYTN_HUMAN/1-1 93.8% 12.8% IIPGGI--YNAD----LNDEWVQRALHFAISEYNKAT--KDDYYRR-PLRVLR-ARQQTVGGVNYFFDVEVG-------- 8 CYTC_HUMAN/1-1 93.8% 12.0% RLVGGP--MDAS----VEEEGVRRALDFAVGEYNKAS--NDMYHSR-ALQVVR-ARKQIVAGVNYFLDVELG-------- 9 CYT_CHICK/1-11 93.8% 12.0% RLLGAP--VPVD----ENDEGLQRALQFAMAEYNRAS--NDKYSSR-VVRVIS-AKRQLVSGIKYILQVEIG-------- 10 CYT_CYPCA/1-11 92.8% 12.8% GIPGGL--VDAD----INDKDVQKALRFAVDHYNGQS--NDAFVRK-VSKVIK-VQQQVAAGMKYIFTVKME-------- 11 Q91195/1-110 92.8% 12.8% GLIGGP--MDAN----MNDQGTRDALQFAVVEHNKKT--NDMFVRQ-VAKVVN-AQKQVVSGMKYIFTVQMG-------- 12 CYT1_ORYSA/1-9 89.7% 15.0% PVLGGV--EPV---GNENDLHLVDLARFAVTEHNKKA--NSLLE---FEKLVS-VKQQVVAGTLYYFTIEVK-------- 13 CYT2_ORYSA/1-9 90.7% 11.7% AREGGR--HPRQPAGRENDLTTVELARFAVAEHNSKA--NAMLE---LERVVK-VRQQVVGGFMHYLTVEVK-------- 14 CYTI_VIGUN/1-9 90.7% 15.0% AALGGN--RDVA--GNQNSLEIDSLARFAVEEHNKKQ--NALLE---FGRVVS-AQQQVVSGTLYTITLEAK-------- 15 Q39841/1-91 90.7% 17.0% QELGGI--TDVH--GAANSVEINNLARFAVEEQNKRE--NSVLE---FVRVIS-AKQQVVAGVNYYITLEAK-------- 16 Q38678/1-91 90.7% 22.0% SILGGI--TEVK--DNDNSVDFDELAKFAIAEHNKKE--NAALE---FGKVIE-KKQQAVQGTMYYIKVEAN-------- 17 Q43635/1-92 90.7% 14.9% TVQGGV--HDSP-QGTANNAEIDGIARFAVDEHNKKE--NAMVE---FGRVLK-AKEQVVAGTLHHLTIEAI-------- 18 G2317876/1-91 89.7% 13.9% AAVGAV--RDN--QGVANSVETESLARYAVDEHNKKE--NDLLE---FVRVLD-DKVQVVSGTMHYLKIEAT-------- 19 Q42380/1-88 86.6% 13.3% ---GTS--RDV--DPNANDLQVESLARFAVDEHNKKE--NVSLE---YRRLIG-AKTQVVAGTMHHLTVEVA-------- 20 Q41906/1-91 90.7% 15.0% MMLGGV--HDLR--GNQNSGEIESLARFAIQEHNKQQ--NKILE---FKKIVK-AREQVVAGTMYHLTLEAK-------- 21 CYTM_SOLTU/2-0 90.7% 17.0% TMPGGI--VNVP---NPNNTKFQELARFAIQDYNKKQ--NAHLE---FVENLN-VKEQVVAGIMYYITLAAT-------- 22 CYTM_SOLTU/1-9 90.7% 16.2% AIVGGL--VDVP---FENKVEFDDLARFAVQDYNQKN--DSSLE---FKKVLN-VKQQIVAGIMYYITFEAT-------- 23 Q39561/1-91 90.7% 19.0% IVIGGL--QDVE--GDANNLEYQELARFAVDEHNKKT--NAMLQ---FKRVVN-VKQAVVEGLKYCITLEAV-------- 24 CYTX_ONCVO/1-1 92.8% 14.4% VLLGGW--EDRD----PKDEEILELLPSILMKVNEQS--NDEYHLM-PIKLLK-VSSQVVAGVKYKMDVQVA-------- 25 Q17108/1-111 92.8% 17.8% NLLGGW--QERN----PEEKEIQDLLPKVLIKLNQLS--NVEYHLM-PIKLLK-VSSQVVAGLRYKMEIQVA-------- 26 CYTL_DROME/1-9 86.6% 12.5% QVVGGV--SQLE---GNSRKEALELLDATLAQLATGD--GPSYK---AINVTS-VTGQVVAGSLNTYEVELD-------- 27 CYTA_SARPE/1-9 86.6% 13.5% QCVGCP--SEVK---GDKLKQSEETLNKSLSKLAAGD--GPTYK---LVKINS-ATTQVVSGSKDVINADLK-------- 28 KNH1_BOVIN/1-1 88.7% 5.0% LTQESS--QEID----CNDQDVFKAVDAALTKYNSENKSGNQFVLY-RITEVA---RMDNPDTFYSLKYQIK-------- 29 KNT1_RAT/1-109 87.6% 5.8% AQEEGA--QELN----CNDETVFQAVDTALKKYNAELESGNQFVLY-RVTEGT---KKDGAETLYSFKYQIK-------- 30 HRG_HUMAN/1-11 89.7% 7.2% LQYSCA---VSP----TDCSAVEPEAEKALDLINKRRRDGYLFQLL-RIADAH--LDRVENTTVYYLVLDVQ-------- 31 KNT1_RAT/2-0 88.7% 10.8% LCVGCF--QPIP----MDSSDLKPVLKHAVEHSNNNTKHTHLFALR-EVKSAH---SQVVAGMNYKIIYSIV-------- 32 O08676/2-0 88.7% 12.5% PCIGCV--HAIS----TDSPDLEPVLKHSIEHFNNNTDHSHLFTLR-KVKSAH---RQVVAGLNFDITYTIV-------- 33 KNH1_BOVIN/2-0 88.7% 10.0% ECLGCV--HPIS----TKSPDLEPVLRYAIQYFNNNTSHSHLFDLK-EVKRAQ---RQVVSGWNYEVNYSIA-------- 34 KNH1_BOVIN/3-0 87.6% 9.9% LCAGCP--KPIP----VDSPDLEEPLSHSIAKLNAEHDGAFYFKID-TVKKAT---VQVVAGLKYSIVFIAR-------- 35 KNT1_RAT/3-0 87.6% 11.6% NCRGCP--REIP----VDSPELKEALGHSIAQLNAQHNHIFYFKID-TVKKAT---SQVVAGVIYVIEFIAR-------- 36 A2HS_BOVIN/2-0 85.6% 4.2% LCPDCP--LLAP----LNDSRVVHAVEVALATFNAESN-GSYLQLV-EISRAQ----FVPLPVSVSVEFAVA-------- 37 A2HS_HUMAN/2-0 84.5% 5.0% VCQDCP--LLAP----LNDTRVVHAAKAALAAFNAQNN-GSNFQLE-EISRAQ----LVPLPPSTYVEFTVS-------- 38 A2HS_MOUSE/2-0 84.5% 1.7% LCPRCP--LLTP----FNDTNVVHTVNTALAAFNTQNN-GTYFKLV-EISRAQ----NVPLPVSTLVEFVIA-------- 39 22P1_RAT/1-144 93.8% 2.7% RGMEIF--EK----NFIDKNKLKDVYDVFKYLYNTHSA-DTYLSN--IKNESF-TMNIWGFGEIEMVKTKCRKIDSDFYK 40 A2HS_MOUSE/1-1 86.6% 6.4% GTGLGF--RE----LACDDPEAEQVALLAVDYLNNHLLQGFKQVLN-QIDKVK-VWSRRPFGVVYEMEVDTL-------- 41 HSF_TRIFL/1-11 85.6% 8.0% DQVRGD--------LECDDKEAKNWADDAVRYINEHKLHGHKQALN-VIKNIC-VVPWNGDLVAVFLELNLL-------- 42 CYTS_RAT/1-111 89.7% 10.7% HFLGGI--EKSS----MEEEGASEALNYAVNEYNEKN--SDLYLSR-VVEVKD-VQKQVVAGTKFFFDVILG-------- 43 Q90517/1-98 87.6% 29.1% TVCGGL--TKTM----QATEEIQAKCDQVKPAVEDKT--GKNYE---VFTAKT-YRSQVVCGMNYFVKVHVG-------- 44 CYTM_HUMAN/1-1 93.8% 12.4% RMVGEL--RDLS----PDDPQVQKAAQAAVASYNMGS--NSIYYFR-DTHIIK-AQSQLVAGIKYFLTMEMG-------- 45 CYT_BITAR/1-11 88.7% 15.8% -IPGGL--SPRD----VTDPDVQEAAAFAVEKYNAGS--KNDYYFK-ERRVVE-AQSQVVSGVKYYLMMELL-------- 46 Q41916/1-90 87.6% 13.9% ARVGGW--SPIS---NVTDPQVVEIGEFAVSEYNKRS--ESGLK---FETVVS-GETQVVSGTNYRLKVAAN-------- 47 E326996/1-89 87.6% 12.1% --LGSR--KPIKN---VSDPDVVAVAKYAIEEHNKES--KEKLV---FVKVVE-GTTQVVSGTKYDLKIAAK-------- 48 P90698/1-105 86.6% 12.3% -RLSRA--TYN-----EDDEEIQEVAEKAMEQVNDQTRYRNLYK---LVRVIS-AQTQVVAGIKYYLTILAA-------- 49 O08692/1-107 86.6% 8.3% LVVALA--VVSCE--ALRQLRYEEIVDRAIEAYNQGRQGRPLFR---LLSATP-PSSQ-NPATNIPLQFRIK-------- 50 G2665886/1-116 93.8% 16.4% MLAGGL--TDQS----TDDPEFMEQAWKAATKVNEEANDGDYYMI--PTKVLS-AKTQVVSGVMFTSKVLFE-------- 51 HSF_TRIFL/2-0 89.7% 7.4% NCSKCP--ILLP----PNNPHVVDSVEYVLNKHNEKLS-GHIYE---VLEISR--GQHKYEPEAYYLEFVIV-------- 52 CRES_MOUSE/1-1 89.7% 8.4% QNYFGS--------INISNANVKQCVWFAMKEYNKES--EDKYVFL-VDKILH-AKLQITDRMEYQIDVQIS-------- 53 HRG_HUMAN/2-0 90.7% 10.9% SALANTKDSPVLIDFFEDTERYRKQANKALEKYKEENDDFASFRVD-RIERVA--RVRGGEGTGYFVDFSVR-------- consensus/100% .................t.......h...h...t...............t..................h.h......... consensus/90% ...ts............tp.th.thhthsh..hpttt..t..h.....hp.ht....ths.s..h.hph.h......... consensus/80% .h.us............ss.ph.phhphshtphNppp..st.h.....hphhp...pplssGh.ahhphtht........ consensus/70% .hhGsh..p.h......ss.chpphhphAltphNppp..sthht...hhchhp.htpQlVsGh.ahlphpht........ cov pid 81 . 1 . . . . : . 160 1 CYT2_MOUSE/1-9 100.0% 100.0% -------------------------HINVLS-------GISSEND-----------------------LELTGYK---AK 2 CYT3_MOUSE/1-9 100.0% 58.8% -------------------------HIKVFN-------GPTGKDN-----------------------YELHGYQ---TD 3 CYTA_RAT/1-97 96.9% 57.0% ------------------------LHMKVLR-------GLSGD-----------------------DDLKLLDYQ---TN 4 CYTA_BOVIN/1-9 97.9% 54.0% -----------------------YIHIKVFK-------SLPQQSHS----------------------LILTGYQ---VD 5 CYTB_BOVIN/1-9 94.8% 45.6% --------------------EDDFVHIRVFE-------SLPHENKP----------------------VALTSYQ---TN 6 CYTD_HUMAN/1-1 93.8% 9.3% -------------------------RTTCTK-------SQPNLDNCPFNDQPKLKEEE-----FCSFQINEVPWE----D 7 CYTN_HUMAN/1-1 93.8% 12.8% -------------------------RTICTK-------SQPNLDTCAFHEQPELQKKQ-----LCSFEIYEVPWE----N 8 CYTC_HUMAN/1-1 93.8% 12.0% -------------------------RTTCTK-------TQPNLDNCPFHDQPHLKRKA-----FCSFQIYAVPWQ----G 9 CYT_CHICK/1-11 93.8% 12.0% -------------------------RTTCPK-------SSGDLQSCEFHDEPEMAKYT-----TCTFVVYSIPWL----N 10 CYT_CYPCA/1-11 92.8% 12.8% -------------------------VASCKK--------GGVKTMCAVPKNPSIEQVI-----QCKITVWSQPWL----N 11 Q91195/1-110 92.8% 12.8% -------------------------RTPCRK--------GGVEKVCSVHKDPQMAVPY-----KCTFEVWSRPWM----S 12 CYT1_ORYSA/1-9 89.7% 15.0% -------------------------EGDAKK----------LYEAK----------------------VWEKPWM----D 13 CYT2_ORYSA/1-9 90.7% 11.7% ------------------------EPGGANK----------LYEAK----------------------VWERAWE----N 14 CYTI_VIGUN/1-9 90.7% 15.0% -------------------------DGGQKK----------VYEAK----------------------VWEKPWL----N 15 Q39841/1-91 90.7% 17.0% -------------------------DGLIKN----------EYEAK----------------------VWVREWL----N 16 Q38678/1-91 90.7% 22.0% -------------------------DGGEKK----------TYEAK----------------------VWVKLWE----N 17 Q43635/1-92 90.7% 14.9% -------------------------EAGKKK----------IYEAK----------------------VWVKPWL----N 18 G2317876/1-91 89.7% 13.9% -------------------------EGGKKK----------VYEAK----------------------VWVKPWE----N 19 Q42380/1-88 86.6% 13.3% -------------------------DGETKK----------VYEAK----------------------VLEKAWE----N 20 Q41906/1-91 90.7% 15.0% -------------------------EGDQTK----------NFEAK----------------------VWVKPWM----N 21 CYTM_SOLTU/2-0 90.7% 17.0% ------------------------DDAGKKK----------IYKAK----------------------IWVKEWE----D 22 CYTM_SOLTU/1-9 90.7% 16.2% -------------------------EGGNKK----------EYEAK----------------------ILLRKWE----D 23 Q39561/1-91 90.7% 19.0% -------------------------DGHKTK----------VYEAE----------------------IWLKLWE----N 24 CYTX_ONCVO/1-1 92.8% 14.4% -------------------------RSQCKKSSNE----KVDLTKCKK-----LEGHPEK---VMTLEVWEKPWE----N 25 Q17108/1-111 92.8% 17.8% -------------------------QSECKKSSGE----EVNLKTCK-----RLEGHPDQ---IITLEAWEKSWE----N 26 CYTL_DROME/1-9 86.6% 12.5% -------------------------NGSDKK--------------------------------QCTVKIWTQPWLK---E 27 CYTA_SARPE/1-9 86.6% 13.5% -------------------------DENDKT-------------------------------KTCDITIWSQPWL----E 28 KNH1_BOVIN/1-1 88.7% 5.0% -------------------------EGDCPFQSNK------TWQDCDYKDS----AQAAT--GECTA-TVAKRG----NM 29 KNT1_RAT/1-109 87.6% 5.8% -------------------------EGNCSVQSGL------TWQDCDFKD-----AEEAAT-GECTT-TLGKKE-----N 30 HRG_HUMAN/1-11 89.7% 7.2% -------------------------ESDCSVLSRK------YWNDCEP-PDSRRPSEIVI--GQCKVIATRHSHE---SQ 31 KNT1_RAT/2-0 88.7% 10.8% -------------------------QTNCSKEDFPS-----LREDCVPL------PYGDH--GECTG-HTHVDIH----N 32 O08676/2-0 88.7% 12.5% -------------------------QTNCSKERFPS-----LHGDCVA------LPNGDD--GECRG-NLFMDIN----N 33 KNH1_BOVIN/2-0 88.7% 10.0% -------------------------QTNCSKEEFSF-----LTPDCKS------LSSGDT--GECTD-KAHVDV----KL 34 KNH1_BOVIN/3-0 87.6% 9.9% -------------------------ETTCSKGSNEE-----LTKSCEIN------IHGQIL--HCDANVYVVPW-----E 35 KNT1_RAT/3-0 87.6% 11.6% -------------------------ETNCSKQSKTE-----LTADCETK------HLGQSL--NCNANVYMRPW-----E 36 A2HS_BOVIN/2-0 85.6% 4.2% -------------------------ATDCIAKEVV------DPTKCNL------LAEKQY--GFCKGSVIQKALG----- 37 A2HS_HUMAN/2-0 84.5% 5.0% -------------------------GTDCVAKEAT------EAAKCNL------LAEKQY--GFCKATLSEKLG------ 38 A2HS_MOUSE/2-0 84.5% 1.7% -------------------------ATDCTAKEVT------DPAKCNL------LAEKQH--GFCKANLMHNLG------ 39 22P1_RAT/1-144 93.8% 2.7% CSFQREFYNLKRTPGETMYYISLPGSVRCRK--LLS-----KLDNCPFEEQ--TEQLKREI---CYFVVYPDYIE----Q 40 A2HS_MOUSE/1-1 86.6% 6.4% -------------------------ETTCHAL-DPT-----PLANCSVRQ---LTEHAVEG--DCDFHILKQDGQ----- 41 HSF_TRIFL/1-11 85.6% 8.0% -------------------------ETECHVL-DPT-----PVEKCTVRQQ---HNHAVEM--DCDAKIMFNVE-----T 42 CYTS_RAT/1-111 89.7% 10.7% -------------------------KTICLKT-QGD------LTNCPLNEE---ADQQEHE--FCSFVVHDIPWE----N 43 Q90517/1-98 87.6% 29.1% -------------------------GDDYIHIRVYEK------LPCHGGDI----------------EVHSVQE-----S 44 CYTM_HUMAN/1-1 93.8% 12.4% -------------------------STDCRKTRVTG--DHVDLTTCPLAAGA---QQEKL---RCDFEVLVVPWQ----N 45 CYT_BITAR/1-11 88.7% 15.8% -------------------------KTTCKKTVGRPK-GYQEIQNCNLP---PENQQEEI---TCRFEVWSRPW------ 46 Q41916/1-90 87.6% 13.9% -------------------------DGDGV------------SKNYL-------------------AIVWVKPW----MK 47 E326996/1-89 87.6% 12.1% -------------------------DGGGKIKN---------YEAV----------------------VVEKLWL----H 48 P90698/1-105 86.6% 12.3% -------------------------PTTCRKGAVG-----MNPMKCTID------SSKPT--KQFKIEVWSAPWQ----N 49 O08692/1-107 86.6% 8.3% -------------------------ETECTSTQER------QPKDCDFL------EDGEER--NCTGKFFRRRQ------ 50 G2665886/1-116 93.8% 16.4% -------------------------ESFCKKGDVPVD--QLKASNCAPK------EGGKRV--IYEISVLLQPWVK--SE 51 HSF_TRIFL/2-0 89.7% 7.4% -------------------------EINCTAQEAHDD-----HHQCHPY------TAGEDHIAFCRSTVFRSHAS---LE 52 CRES_MOUSE/1-1 89.7% 8.4% -------------------------RSNCKK-------PLNNTENCIPQK---KPELEKK--MSCSFLVGALPW----NG 53 HRG_HUMAN/2-0 90.7% 10.9% ---------------------------NCPR--------HHFPRHPNVF-------------GFCRADLFYDVEAL-DLE consensus/100% ................................................................................ consensus/90% .........................t.t........................................hh...h...... consensus/80% .........................psts.t............ttp......................lh.h.h.....p consensus/70% .........................cssspp...........hpsp......................lh.psa.....p cov pid 161 ] 170 1 CYT2_MOUSE/1-9 100.0% 100.0% QTNNDELTYF 2 CYT3_MOUSE/1-9 100.0% 58.8% KTMDEELTYF 3 CYTA_RAT/1-97 96.9% 57.0% KTKNDELTDF 4 CYTA_BOVIN/1-9 97.9% 54.0% KTKDDELAGF 5 CYTB_BOVIN/1-9 94.8% 45.6% KGRHDELTYF 6 CYTD_HUMAN/1-1 93.8% 9.3% KISILNYKCR 7 CYTN_HUMAN/1-1 93.8% 12.8% RRSLVKSRCQ 8 CYTC_HUMAN/1-1 93.8% 12.0% TMTLSKSTCQ 9 CYT_CHICK/1-11 93.8% 12.0% QIKLLESKCQ 10 CYT_CYPCA/1-11 92.8% 12.8% SLKVTENTCM 11 Q91195/1-110 92.8% 12.8% DIQMVKNQCE 12 CYT1_ORYSA/1-9 89.7% 15.0% FKELQEFKPV 13 CYT2_ORYSA/1-9 90.7% 11.7% FKQLQDFKPL 14 CYTI_VIGUN/1-9 90.7% 15.0% FKELQEFKHV 15 Q39841/1-91 90.7% 17.0% SKELLEFKPV 16 Q38678/1-91 90.7% 22.0% FKELQELKLV 17 Q43635/1-92 90.7% 14.9% FKELQEFKHA 18 G2317876/1-91 89.7% 13.9% FKQVQEFKPV 19 Q42380/1-88 86.6% 13.3% LKKLEDFTHL 20 Q41906/1-91 90.7% 15.0% FKQLQEFKES 21 CYTM_SOLTU/2-0 90.7% 17.0% FKKVVEFKLV 22 CYTM_SOLTU/1-9 90.7% 16.2% LKKVVGFKLV 23 Q39561/1-91 90.7% 19.0% FRSLEGFKLL 24 CYTX_ONCVO/1-1 92.8% 14.4% FMRVEILGTK 25 Q17108/1-111 92.8% 17.8% FLQVKILEKK 26 CYTL_DROME/1-9 86.6% 12.5% NGTNIKIKCS 27 CYTA_SARPE/1-9 86.6% 13.5% NGIEVTFNCP 28 KNH1_BOVIN/1-1 88.7% 5.0% KFSVAIQTCL 29 KNT1_RAT/1-109 87.6% 5.8% KFSVATQICN 30 HRG_HUMAN/1-11 89.7% 7.2% DLRVIDFNCT 31 KNT1_RAT/2-0 88.7% 10.8% TIAGFSQSCD 32 O08676/2-0 88.7% 12.5% KIANFSQSCT 33 KNH1_BOVIN/2-0 88.7% 10.0% RISSFSQKCD 34 KNH1_BOVIN/3-0 87.6% 9.9% EKVYPTVNCQ 35 KNT1_RAT/3-0 87.6% 11.6% NKVVPTVRCQ 36 A2HS_BOVIN/2-0 85.6% 4.2% -GEDVRVTCT 37 A2HS_HUMAN/2-0 84.5% 5.0% -GAEVAVTCT 38 A2HS_MOUSE/2-0 84.5% 1.7% -GEEVSVACK 39 22P1_RAT/1-144 93.8% 2.7% NIHAVRFDCY 40 A2HS_MOUSE/1-1 86.6% 6.4% -FRVMHTQCH 41 HSF_TRIFL/1-11 85.6% 8.0% FKRDVFVKCH 42 CYTS_RAT/1-111 89.7% 10.7% YIVLLSSSCH 43 Q90517/1-98 87.6% 29.1% KTLADPIEYL 44 CYTM_HUMAN/1-1 93.8% 12.4% SSQLLKHNCV 45 CYT_BITAR/1-11 88.7% 15.8% -LPSTSLTK- 46 Q41916/1-90 87.6% 13.9% FRNLTSFEP- 47 E326996/1-89 87.6% 12.1% SKSLESFKAL 48 P90698/1-105 86.6% 12.3% TFKVTLT--- 49 O08692/1-107 86.6% 8.3% -STSLTLTCD 50 G2665886/1-116 93.8% 16.4% QVGVKVLRVF 51 HSF_TRIFL/2-0 89.7% 7.4% KPKDEKFESD 52 CRES_MOUSE/1-1 89.7% 8.4% EFNLLSKECK 53 HRG_HUMAN/2-0 90.7% 10.9% SPKNLVINCE consensus/100% .......... consensus/90% .h.....p.. consensus/80% .ht..t.ph. consensus/70% .hp..phps.